Literature DB >> 10077147

First cytogenetic study of a recurrent familial chordoma of the clivus.

L Dalprà1, R Malgara, M Miozzo, P Riva, M Volonte, L Larizza, A M Fuhrman Conti.   

Abstract

Two recurrences of a familial clivus chordoma, arisen from a patient who developed the primary tumor at age of 8 years, were investigated by cytogenetic and the fluorescence in situ hybridization (FISH) approach. Of the patient's 3 daughters, 2 developed, respectively, a clivus chordoma and an astrocytoma in infancy, a familial aggregation highly suggestive of a genetic background. After a 31-year hiatus, 2 tumor recurrences, developed over 17 months, were removed surgically. Both were hypo- or nearly diploid, and had a pronounced karyotypic heterogeneity with clonal and non-clonal rearrangements affecting several chromosomes. The same rearrangement, a dic(1;9)(p36.1;p21), was shared in both tumor specimens and, in 90% of the cells, chromosome 1p appeared to be involved in unbalanced translocations with different chromosomes, leading to variable losses of 1p. Previous cytogenetic data concerning chordoma are limited to 10 sporadic tumors with an abnormal karyotype; although no tumor-specific rearrangements have been identified, chromosome 1p appears to be involved frequently.

Entities:  

Mesh:

Year:  1999        PMID: 10077147     DOI: 10.1002/(sici)1097-0215(19990331)81:1<24::aid-ijc5>3.0.co;2-o

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  Clinical findings in families with chordoma with and without T gene duplications and in patients with sporadic chordoma reported to the Surveillance, Epidemiology, and End Results program.

Authors:  Dilys M Parry; Mary L McMaster; Norbert J Liebsch; Nicholas J Patronas; Martha M Quezado; Deborah Zametkin; Xiaohong R Yang; Alisa M Goldstein
Journal:  J Neurosurg       Date:  2020-06-19       Impact factor: 5.115

Review 2.  Current therapeutic options and novel molecular markers in skull base chordomas.

Authors:  Filippo Gagliardi; Nicola Boari; Paola Riva; Pietro Mortini
Journal:  Neurosurg Rev       Date:  2011-10-18       Impact factor: 3.042

3.  The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas.

Authors:  Craig Horbinski; Gerard J Oakley; Kathleen Cieply; Geeta S Mantha; Marina N Nikiforova; Sanja Dacic; Raja R Seethala
Journal:  Arch Pathol Lab Med       Date:  2010-08       Impact factor: 5.534

4.  Familial chordoma: A case report and review of the literature.

Authors:  K E Wang; Zhen Wu; Kaibing Tian; Liang Wang; Shuyu Hao; Liwei Zhang; Junting Zhang
Journal:  Oncol Lett       Date:  2015-09-09       Impact factor: 2.967

5.  Clinical features distinguish childhood chordoma associated with tuberous sclerosis complex (TSC) from chordoma in the general paediatric population.

Authors:  Mary L McMaster; Alisa M Goldstein; Dilys M Parry
Journal:  J Med Genet       Date:  2011-01-25       Impact factor: 6.318

6.  Familial chordoma, a tumor of notochordal remnants, is linked to chromosome 7q33.

Authors:  M J Kelley; J F Korczak; E Sheridan; X Yang; A M Goldstein; D M Parry
Journal:  Am J Hum Genet       Date:  2001-07-10       Impact factor: 11.025

7.  Update on the cytogenetics and molecular genetics of chordoma.

Authors:  Lidia Larizza; Pietro Mortini; Paola Riva
Journal:  Hered Cancer Clin Pract       Date:  2005-02-15       Impact factor: 2.857

8.  Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin.

Authors:  Lucia Ricci-Vitiani; Daniele Runci; Quintino Giorgio D'Alessandris; Tonia Cenci; Maurizio Martini; Federico Bianchi; Giulio Maira; Louis Stancato; Ruggero De Maria; Luigi Maria Larocca; Roberto Pallini
Journal:  Neoplasia       Date:  2013-07       Impact factor: 5.715

9.  Chordoma in the lateral medullary cistern in a patient with tuberous sclerosis: A case report and review of the literature.

Authors:  Kristopher T Kimmell; Hayan Dayoub; Ethan D Stolzenberg; Eric H Sincoff
Journal:  Surg Neurol Int       Date:  2010-05-31

10.  Chordoma characterization of significant changes of the DNA methylation pattern.

Authors:  Beate Rinner; Andreas Weinhaeusel; Birgit Lohberger; Elke Verena Froehlich; Walter Pulverer; Carina Fischer; Katharina Meditz; Susanne Scheipl; Slave Trajanoski; Christian Guelly; Andreas Leithner; Bernadette Liegl
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.